Business Of Biotech An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.
Sep 23, 2024
Hilary Eaton, Ph.D., is the Chief Business Officer at ProFluent Bio, where she champions open-source AI gene editing tools. Once a skeptic of AI in drug discovery, her perspective shifted after personal and professional challenges. She delves into her transformative journey from molecular biology to business, the emotional strains of parenting a child with a rare disorder, and the critical role of genetics in therapeutic innovation. Hilary also discusses the importance of collaboration in advancing biotech through AI, emphasizing resilience and support in the industry.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Intro
00:00 • 4min
From Research to Real-World Impact
03:46 • 9min
Navigating Hypermobile Ehlers-Danlos Syndrome
12:27 • 7min
The Interplay of Genetics and Therapeutic Development
19:07 • 3min
Navigating Rare Disease Parenting with Expertise and Support
22:29 • 2min
Navigating Biotech: A Personal Journey through Disease and Innovation
24:34 • 30min
Iterative Data Validation in Scientific Research
54:35 • 2min
AI and Open Innovation in Biotech
56:45 • 17min